Metabotropic Glutamate Receptor-5 (mGlur5) Effects on Reward-Related fMRI-BOLD Activation in FHP and FHN
Status:
Completed
Trial end date:
2019-11-13
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to evaluate the role of Mavoglurant in clarifying the
neurobiology of alcoholism risk. This is a 1-site, randomized, within subjects,
counterbalanced double-blind study of a single dose (200mg) of Mavoglurant and placebo.